checkAd

     101  0 Kommentare AdvanSix Announces Second Quarter 2023 Financial Results

    AdvanSix (NYSE: ASIX) today announced its financial results for the second quarter ending June 30, 2023. Overall, the Company delivered solid earnings and cash flow results amid a continued dynamic macro environment.

    Second Quarter 2023 Summary

    • Sales down approximately 27% versus prior year driven by 19% unfavorable impact of market-based pricing, 6% lower raw material pass-through pricing, and 2% lower volume
    • Net Income of $32.7 million, a decrease of $32.4 million versus the prior year
    • Adjusted EBITDA of $65.8 million, a decrease of $39.6 million versus the prior year
    • Cash Flow from Operations of $35.0 million, a decrease of $60.9 million versus the prior year
    • Capital Expenditures of $19.3 million, an increase of $1.5 million versus the prior year
    • Free Cash Flow of $15.7 million, a decrease of $62.4 million versus the prior year
    • Repurchased 410,862 shares for approximately $14.9 million in 2Q23

    “AdvanSix successfully delivered solid earnings and cash flow results in the second quarter against a record prior year,” said Erin Kane, president and CEO of AdvanSix. “The AdvanSix team executed well within a mixed set of dynamics across the portfolio. We captured strong in-season demand for plant nutrients in a significantly lower nitrogen and raw material environment, navigated a nylon pricing environment pressured by industry supply and demand conditions including increased low-priced imports, while North American acetone supply and demand continued to be balanced. Our team’s collective performance and advantaged business model supporting through-cycle profitability illustrates the value and resilience of our diversified chemistry company. Our confidence is reflected in once again increasing our quarterly cash dividend by 10 percent.”

    Summary second quarter 2023 financial results for the Company are included below:

    ($ in Thousands, Except Earnings Per Share)

    2Q 2023

     

    2Q 2022

    Sales

    $427,940

     

    $583,736

    Net Income

    32,728

     

    65,157

    Diluted Earnings Per Share

    $1.16

     

    $2.23

    Adjusted Diluted Earnings Per Share (1)

    $1.25

     

    $2.30

    Adjusted EBITDA (1)

    65,785

     

    105,426

    Adjusted EBITDA Margin % (1)

    15.4%

     

    18.1%

    Cash Flow from Operations

    35,004

     

    95,891

    Free Cash Flow (1)(2)

    15,713

     

    78,131

    (1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations

    (2) Net cash provided by operating activities less capital expenditures

    Sales of $428 million in the quarter decreased approximately 27% versus the prior year. Market-based pricing was unfavorable by 19% compared to the prior year primarily reflecting lower nutrient values reducing ammonium sulfate pricing, as well as lower nylon pricing. Raw material pass-through pricing was unfavorable by 6% following a net cost decrease in benzene and propylene (inputs to cumene which is a key feedstock to our products). Sales volume decreased approximately 2% driven by soft end market demand impacting portions of our nylon and chemical intermediates product lines, partially offset by higher domestic ammonium sulfate volume to meet strong in-season customer demand.

    Sales by product line and approximate percentage of total sales are included below:

    ($ in Thousands)

    2Q 2023

     

    2Q 2022

     

    Sales

     

    % of Total

     

    Sales

     

    % of Total

    Nylon

    $

    92,953

     

    22%

     

    $

    132,105

     

    23 %

    Caprolactam

     

    74,682

     

    18 %

     

     

    87,169

     

    15 %

    Chemical Intermediates

     

    121,365

     

    28 %

     

     

    158,611

     

    27 %

    Ammonium Sulfate

     

    138,940

     

    32 %

     

     

    205,851

     

    35 %

     

    $

    427,940

     

    100 %

     

    $

    583,736

     

    100 %

    Adjusted EBITDA of $65.8 million in the quarter decreased $39.6 million versus the prior year primarily due to unfavorable market-based pricing, net of raw material costs, partially offset by the favorable year-over-year impact of planned plant turnarounds, and the net impact of lower sales volume and changes in sales mix including higher domestic plant nutrients sales.

    Adjusted earnings per share of $1.25 decreased $1.05 versus the prior year driven primarily by the factors discussed above.

    Cash flow from operations of $35.0 million in the quarter decreased $60.9 million versus the prior year primarily due to lower net income and the unfavorable impact of changes in working capital driven largely by the unwinding of ammonium sulfate pre-buy advances. Capital expenditures of $19.3 million in the quarter increased $1.5 million versus the prior year.

    Dividend

    The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. This represents a 10% increase from the previous quarter's dividend. The dividend is payable on August 29, 2023 to stockholders of record as of the close of business on August 15, 2023.

    Outlook

    • Expect favorable underlying agriculture industry fundamentals to continue; Typical North American ammonium sulfate seasonality expected to drive 3Q23 sequential domestic pricing decline
    • Expect balanced supply and demand conditions for North American acetone to continue
    • Expect continued unfavorable supply and demand conditions across nylon and other chemical intermediates due to headwinds in consumer durables and building and construction end markets
    • Continue to expect Capital Expenditures of $110 million to $120 million in 2023, reflecting increased spend due to critical infrastructure, other maintenance, and growth and cost savings projects
    • Continue to expect pre-tax income impact of planned plant turnarounds to be $25 million to $30 million in 3Q23, totaling $28 million to $33 million in full year 2023

    "We are highly focused on the execution of our upcoming third quarter planned plant turnaround to support safe, stable and sustainable operations at higher utilization rates relative to our industry. While we anticipate the impacts of ammonium sulfate seasonality and soft end market demand overall, we remain well positioned to offer near, medium and long-term value for our shareholders supported by the structural improvements made to the underlying earnings power of this business. We are committed to producing the right chemistries with the right properties to solve our customers' most exciting opportunities, recently illustrated by the introduction of new 100 percent post-consumer recycled content nylon,” concluded Kane.

    Conference Call Information

    AdvanSix will discuss its results during its investor conference call today starting at 9:00 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:00 a.m. ET start, and tell the operator that you are dialing in for AdvanSix’s second quarter 2023 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on August 4 until 12 noon ET on August 11 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 9404240.

    About AdvanSix

    AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people’s lives. Our integrated value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, chemical intermediates, and plant nutrients. More information on AdvanSix can be found at http://www.advansix.com.

    Forward Looking Statements

    This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally, including the impact of the coronavirus (COVID-19) pandemic and any resurgences; the potential effects of inflationary pressures, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of the conflict between Russia and Ukraine; the effect on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks and disruptions to our technology infrastructure; risks associated with employees working remotely or operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics and geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; cybersecurity, data privacy incidents and disruptions to our technology infrastructure; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022, as updated in subsequent reports filed with the SEC.

    Non-GAAP Financial Measures

    This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

    AdvanSix Inc.

    Condensed Consolidated Balance Sheets

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    June 30, 2023

     

    December 31, 2022

    ASSETS

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    10,536

     

     

    $

    30,985

     

    Accounts and other receivables – net

     

    153,148

     

     

     

    175,429

     

    Inventories – net

     

    225,986

     

     

     

    215,502

     

    Taxes receivable

     

    1,442

     

     

     

    9,771

     

    Other current assets

     

    20,043

     

     

     

    9,241

     

    Total current assets

     

    411,155

     

     

     

    440,928

     

     

     

     

     

    Property, plant and equipment – net

     

    816,885

     

     

     

    811,065

     

    Operating lease right-of-use assets

     

    109,816

     

     

     

    114,688

     

    Goodwill

     

    56,192

     

     

     

    56,192

     

    Intangible assets

     

    47,717

     

     

     

    49,242

     

    Other assets

     

    25,244

     

     

     

    23,216

     

    Total assets

    $

    1,467,009

     

     

    $

    1,495,331

     

     

     

     

     

    LIABILITIES

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    220,158

     

     

    $

    272,770

     

    Accrued liabilities

     

    43,310

     

     

     

    48,820

     

    Operating lease liabilities – short-term

     

    34,342

     

     

     

    37,472

     

    Deferred income and customer advances

     

    2,333

     

     

     

    34,430

     

    Total current liabilities

     

    300,143

     

     

     

    393,492

     

     

     

     

     

    Deferred income taxes

     

    164,256

     

     

     

    160,409

     

    Operating lease liabilities – long-term

     

    75,829

     

     

     

    77,571

     

    Line of credit – long-term

     

    140,000

     

     

     

    115,000

     

    Postretirement benefit obligations

     

    2,279

     

     

     

     

    Other liabilities

     

    10,143

     

     

     

    10,679

     

    Total liabilities

     

    692,650

     

     

     

    757,151

     

     

     

     

     

    STOCKHOLDERS' EQUITY

     

     

     

    Common stock, par value $0.01; 200,000,000 shares authorized; 32,577,862 shares issued and 27,302,873 outstanding at June 30, 2023; 31,977,593 shares issued and 27,446,520 outstanding at December 31, 2022

     

    326

     

     

     

    320

     

    Preferred stock, par value $0.01; 50,000,000 shares authorized and 0 shares issued and outstanding at June 30, 2023 and December 31, 2022

     

     

     

     

     

    Treasury stock at par (5,274,989 shares at June 30, 2023; 4,531,073 shares at December 31, 2022)

     

    (53

    )

     

     

    (45

    )

    Additional paid-in capital

     

    151,706

     

     

     

    174,585

     

    Retained earnings

     

    626,885

     

     

     

    567,517

     

    Accumulated other comprehensive loss

     

    (4,505

    )

     

     

    (4,197

    )

    Total stockholders' equity

     

    774,359

     

     

     

    738,180

     

    Total liabilities and stockholders' equity

    $

    1,467,009

     

     

    $

    1,495,331

     

    AdvanSix Inc.

    Condensed Consolidated Statements of Operations

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

    2023

     

     

     

    2022

     

    Sales

    $

    427,940

     

     

    $

    583,736

     

    $

    828,484

     

     

    $

    1,062,809

     

     

     

     

     

     

     

     

     

    Costs, expenses and other:

     

     

     

     

     

     

     

    Costs of goods sold

     

    360,017

     

     

     

    476,835

     

     

    690,059

     

     

     

    852,482

     

    Selling, general and administrative expenses

     

    24,011

     

     

     

    20,841

     

     

    49,126

     

     

     

    42,051

     

    Interest expense, net

     

    1,954

     

     

     

    769

     

     

    3,221

     

     

     

    1,332

     

    Other non-operating (income) expense, net

     

    (1,325

    )

     

     

    172

     

     

    (1,433

    )

     

     

    (431

    )

    Total costs, expenses and other

     

    384,657

     

     

     

    498,617

     

     

    740,973

     

     

     

    895,434

     

     

     

     

     

     

     

     

     

    Income before taxes

     

    43,283

     

     

     

    85,119

     

     

    87,511

     

     

     

    167,375

     

    Income tax expense

     

    10,555

     

     

     

    19,962

     

     

    19,829

     

     

     

    39,145

     

    Net income

    $

    32,728

     

     

    $

    65,157

     

    $

    67,682

     

     

    $

    128,230

     

     

     

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

     

     

     

    Basic

    $

    1.19

     

     

    $

    2.31

     

    $

    2.46

     

     

    $

    4.55

     

    Diluted

    $

    1.16

     

     

    $

    2.23

     

    $

    2.39

     

     

    $

    4.37

     

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    27,494,555

     

     

     

    28,168,207

     

     

    27,547,874

     

     

     

    28,183,951

     

    Diluted

     

    28,113,402

     

     

     

    29,262,709

     

     

    28,348,266

     

     

     

    29,316,792

     

    AdvanSix Inc.

    Condensed Consolidated Statements of Cash Flows

    (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Cash flows from operating activities:

     

     

     

     

     

     

     

    Net income

    $

    32,728

     

     

    $

    65,157

     

     

    $

    67,682

     

     

    $

    128,230

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

     

    Depreciation and amortization

     

    18,113

     

     

     

    17,534

     

     

     

    35,958

     

     

     

    34,226

     

    Loss on disposal of assets

     

    400

     

     

     

    441

     

     

     

    568

     

     

     

    800

     

    Deferred income taxes

     

    4,064

     

     

     

    3,077

     

     

     

    3,894

     

     

     

    2,558

     

    Stock-based compensation

     

    2,436

     

     

     

    2,005

     

     

     

    4,449

     

     

     

    5,379

     

    Amortization of deferred financing fees

     

    154

     

     

     

    154

     

     

     

    309

     

     

     

    309

     

    Changes in assets and liabilities, net of business acquisitions:

     

     

     

     

     

     

     

    Accounts and other receivables

     

    8,116

     

     

     

    (23,743

    )

     

     

    22,123

     

     

     

    (52,145

    )

    Inventories

     

    (1,351

    )

     

     

    4,901

     

     

     

    (10,484

    )

     

     

    3,012

     

    Taxes receivable

     

    (419

    )

     

     

     

     

     

    8,329

     

     

     

     

    Accounts payable

     

    6,172

     

     

     

    42,535

     

     

     

    (47,216

    )

     

     

    52,439

     

    Accrued liabilities

     

    2,664

     

     

     

    2,897

     

     

     

    (5,744

    )

     

     

    (8,821

    )

    Deferred income and customer advances

     

    (23,339

    )

     

     

    (827

    )

     

     

    (32,097

    )

     

     

    (1,142

    )

    Other assets and liabilities

     

    (14,734

    )

     

     

    (18,240

    )

     

     

    (11,192

    )

     

     

    (19,792

    )

    Net cash provided by operating activities

     

    35,004

     

     

     

    95,891

     

     

     

    36,579

     

     

     

    145,053

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

     

     

     

     

    Expenditures for property, plant and equipment

     

    (19,291

    )

     

     

    (17,760

    )

     

     

    (43,894

    )

     

     

    (38,779

    )

    Acquisition of businesses

     

     

     

     

    1,133

     

     

     

     

     

     

    (97,456

    )

    Other investing activities

     

    (1,031

    )

     

     

    (925

    )

     

     

    (2,034

    )

     

     

    (1,221

    )

    Net cash used for investing activities

     

    (20,322

    )

     

     

    (17,552

    )

     

     

    (45,928

    )

     

     

    (137,456

    )

     

     

     

     

     

     

     

     

    Cash flows from financing activities:

     

     

     

     

     

     

     

    Borrowings from line of credit

     

    152,500

     

     

     

    82,000

     

     

     

    230,500

     

     

     

    230,500

     

    Payments of line of credit

     

    (139,500

    )

     

     

    (155,500

    )

     

     

    (205,500

    )

     

     

    (219,000

    )

    Principal payments of finance leases

     

    (225

    )

     

     

    (244

    )

     

     

    (456

    )

     

     

    (481

    )

    Dividend payments

     

    (3,984

    )

     

     

    (3,515

    )

     

     

    (8,004

    )

     

     

    (7,032

    )

    Purchase of treasury stock

     

    (14,886

    )

     

     

    (3,407

    )

     

     

    (28,385

    )

     

     

    (10,419

    )

    Issuance of common stock

     

    123

     

     

     

    318

     

     

     

    745

     

     

     

    1,032

     

    Net cash used for financing activities

     

    (5,972

    )

     

     

    (80,348

    )

     

     

    (11,100

    )

     

     

    (5,400

    )

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    8,710

     

     

     

    (2,009

    )

     

     

    (20,449

    )

     

     

    2,197

     

    Cash and cash equivalents at beginning of period

     

    1,826

     

     

     

    19,306

     

     

     

    30,985

     

     

     

    15,100

     

    Cash and cash equivalents at the end of period

    $

    10,536

     

     

    $

    17,297

     

     

    $

    10,536

     

     

    $

    17,297

     

     

     

     

     

     

     

     

     

    Supplemental non-cash investing activities:

     

     

     

     

     

     

     

    Capital expenditures included in accounts payable

     

     

     

     

    $

    9,832

     

     

    $

    9,207

     

    AdvanSix Inc.

    Non-GAAP Measures

    (Dollars in thousands, except share and per share amounts)

    Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net cash provided by operating activities

    $

    35,004

     

     

    $

    95,891

     

     

    $

    36,579

     

     

    $

    145,053

     

    Expenditures for property, plant and equipment

     

    (19,291

    )

     

     

    (17,760

    )

     

     

    (43,894

    )

     

     

    (38,779

    )

    Free cash flow (1)

    $

    15,713

     

     

    $

    78,131

     

     

    $

    (7,315

    )

     

    $

    106,274

     

     

     

     

     

     

     

     

     

    (1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment

    The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

    Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net income

    $

    32,728

     

     

    $

    65,157

     

     

    $

    67,682

     

     

    $

    128,230

     

    Non-cash stock-based compensation

     

    2,436

     

     

     

    2,005

     

     

     

    4,449

     

     

     

    5,379

     

    Non-recurring, unusual or extraordinary expenses

     

     

     

     

     

     

     

     

     

     

     

    Non-cash amortization from acquisitions

     

    532

     

     

     

    551

     

     

     

    1,064

     

     

     

    752

     

    Non-recurring M&A costs

     

     

     

     

     

     

     

     

     

     

    277

     

    Benefit from income taxes relating to reconciling items

     

    (498

    )

     

     

    (439

    )

     

     

    (933

    )

     

     

    (995

    )

    Adjusted Net Income

     

    35,198

     

     

     

    67,274

     

     

     

    72,262

     

     

     

    133,643

     

    Interest expense, net

     

    1,954

     

     

     

    769

     

     

     

    3,221

     

     

     

    1,332

     

    Income tax expense - adjusted

     

    11,053

     

     

     

    20,401

     

     

     

    20,763

     

     

     

    40,141

     

    Depreciation and amortization - adjusted

     

    17,580

     

     

     

    16,982

     

     

     

    34,893

     

     

     

    33,474

     

    Adjusted EBITDA

    $

    65,785

     

     

    $

    105,426

     

     

    $

    131,139

     

     

    $

    208,590

     

     

     

     

     

     

     

     

     

    Sales

    $

    427,940

     

     

    $

    583,736

     

     

    $

    828,484

     

     

    $

    1,062,809

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA Margin (2)

     

    15.4

    %

     

     

    18.1

    %

     

     

    15.8

    %

     

     

    19.6

    %

     

     

     

     

     

     

     

     

    (2) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales

     

     

     

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

    2022

     

     

    2023

     

     

    2022

    Net Income

    $

    32,728

     

    $

    65,157

     

    $

    67,682

     

    $

    128,230

    Adjusted Net Income

     

    35,198

     

     

    67,274

     

     

    72,262

     

     

    133,643

     

     

     

     

     

     

     

     

    Weighted-average number of common shares outstanding - basic

     

    27,494,555

     

     

    28,168,207

     

     

    27,547,874

     

     

    28,183,951

    Dilutive effect of equity awards and other stock-based holdings

     

    618,847

     

     

    1,094,502

     

     

    800,392

     

     

    1,132,841

    Weighted-average number of common shares outstanding - diluted

     

    28,113,402

     

     

    29,262,709

     

     

    28,348,266

     

     

    29,316,792

     

     

     

     

     

     

     

     

    EPS - Basic

    $

    1.19

     

    $

    2.31

     

    $

    2.46

     

    $

    4.55

    EPS - Diluted

    $

    1.16

     

    $

    2.23

     

    $

    2.39

     

    $

    4.37

    Adjusted EPS - Basic

    $

    1.28

     

    $

    2.39

     

    $

    2.62

     

    $

    4.74

    Adjusted EPS - Diluted

    $

    1.25

     

    $

    2.30

     

    $

    2.55

     

    $

    4.56

     

    The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.

    AdvanSix Inc.

    Appendix

    (Pre-tax income impact, Dollars in millions)

    Planned Plant Turnaround Schedule (3)

     

    1Q

    2Q

    3Q

    4Q

    FY

    2017

    ~$10

    ~$4

    ~$20

    ~$34

    2018

    ~$2

    ~$10

    ~$30

    ~$42

    2019

    ~$5

    ~$5

    ~$25

    ~$35

    2020

    ~$2

    ~$7

    ~$20

    ~$2

    ~$31

    2021

    ~$3

    ~$8

    ~$18

    ~$29

    2022

    ~$1

    ~$5

    ~$44

    ~$50

    2023E

    ~$2

    ~$1

    $25-$30

    $28-$33

    (3) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

     


    The AdvanSix Stock at the time of publication of the news with a fall of -0,55 % to 36,20EUR on Tradegate stock exchange (03. August 2023, 22:26 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    AdvanSix Announces Second Quarter 2023 Financial Results AdvanSix (NYSE: ASIX) today announced its financial results for the second quarter ending June 30, 2023. Overall, the Company delivered solid earnings and cash flow results amid a continued dynamic macro environment. Second Quarter 2023 Summary …